Status:
UNKNOWN
Investigation of Hypophosphataemia Following Intravenous Iron
Lead Sponsor:
Belfast Health and Social Care Trust
Conditions:
Hypophosphatemia
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Anaemia (low haemoglobin levels) can develop in a number of conditions, including chronic kidney disease (CKD) and intestinal conditions (e.g. inflammatory bowel disease, intestinal failure). Intraven...
Detailed Description
Low levels of iron can lead to anaemia, known as iron deficiency anaemia, which can be debilitating due to symptoms such as shortness of breath, fatigue, and dizziness. Iron deficiency anaemia can be ...
Eligibility Criteria
Inclusion
- For Patients
- aged 18 years or older
- previously diagnosed with intestinal failure or advanced CKD
- have anaemia requiring administration of intravenous iron
- be able to adequately speak and understand English
- Have capacity to give written informed consent
- For Healthy Volunteers
- aged 18 years or more
- be able to adequately speak and understand English
- have capacity to give written informed consent
Exclusion
- For patients
- have dialysis-dependent CKD
- participation in any other study which will affect results of the current study
- For Healthy Volunteers
- have CKD (eGFR \<60 mls/min/1.73\^2)
- history of any form of metabolic bone disease
- Participation in any other study which will affect the results of the current study
Key Trial Info
Start Date :
October 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04502784
Start Date
October 7 2019
End Date
December 31 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Belfast Health and Social Care Trust
Belfast, United Kingdom